The abstract is read at the publisher; the summary is JClub's.
PKCα phosphorylates cGAS at Ser120 to drive its nuclear translocation in triple-negative breast cancer, where nuclear cGAS stabilizes β-catenin and promotes metastasis.
- Why it matters: Nuclear cGAS functions in cancer metastasis are unclear, and a STING-independent mechanism linking nuclear cGAS to metastatic signaling is needed.
- What they did: The study identifies a STING-independent pathway in TNBC where PKCα-mediated Ser120 phosphorylation enables nuclear cGAS, which disrupts β-catenin–TRIM33 binding to prevent β-catenin ubiquitination. It also tests TAT peptides that inhibit cGAS phosphorylation and examines TNBC cohorts for nuclear cGAS associations with metastasis.
- The result: In TNBC, blocking cGAS phosphorylation with TAT peptides significantly reduces metastasis, and elevated nuclear cGAS expression is associated with increased metastasis in TNBC cohorts, supporting a PKCα–cGAS–TRIM33 axis as a theragnostic target.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.